Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection.
Muñoz Sandoval D. et al, (2025), J Exp Med, 222
Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth Inhibition.
Tangie E. et al, (2025), Immunology
Click biology highlights the opportunities from reliable biological reactions.
Howarth MR., (2025), Nat Chem Biol
NanoBondy reacting through NeissLock anhydride allows covalent immune cell decoration
Vankayala LR. et al, (2025)
Respiratory viral detection in children hospitalized with pneumonia during periods of major population disruptions in Nepal, 2014-2018.
Shrestha S. et al, (2025), J Pediatric Infect Dis Soc
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study.
Tiley KS. et al, (2025), J Infect
Identification of cross-stage, cross-species malaria CD8+ T cell antigens.
Junqueira C. et al, (2025), Res Sq
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.
Marshall JL. et al, (2025), Nat Commun, 16
Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates
Belghith AA. et al, (2025), Nature Communications, 16
The TyphiNET data visualisation dashboard: unlocking Salmonella Typhi genomics data to support public health.
Dyson ZA. et al, (2025), Genome Med, 17
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
Dold C. et al, (2025), Science Translational Medicine, 17
Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.
Ibarz-Pavon AB. et al, (2025), Vaccine, 56
Origin, evolution, and success of pbla, the gonococcal beta-lactamase plasmid, and implications for public health
MAIDEN MC. et al, (2025), PLoS Pathogens
Priorities for rapid and cost-effective vaccines to improve outbreak responses
Gilbert SC., (2025), PLOS Biology, 23, e3003114 - e3003114
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.
Mellors J. et al, (2025), Nat Commun, 16